Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
暂无分享,去创建一个
[1] C. Lebrilla,et al. Purification, characterization, and N‐glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures , 2018, Biotechnology and bioengineering.
[2] N. Smargiasso,et al. Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans , 2017, Front. Plant Sci..
[3] Yoram Tekoah,et al. Establishment of a tobacco BY2 cell line devoid of plant‐specific xylose and fucose as a platform for the production of biotherapeutic proteins , 2017, Plant biotechnology journal.
[4] C. Lebrilla,et al. Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana , 2017, International journal of molecular sciences.
[5] Florian M. Wurm,et al. Manufacture of Recombinant Therapeutic Proteins Using Chinese Hamster Ovary Cells in Large‐Scale Bioreactors , 2016 .
[6] Qiang Chen. Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms , 2016, Proceedings of the National Academy of Sciences.
[7] S. Werner,et al. Engineering of complex protein sialylation in plants , 2016, Proceedings of the National Academy of Sciences.
[8] M. Sack,et al. Putting the Spotlight Back on Plant Suspension Cultures , 2016, Front. Plant Sci..
[9] Yoram Tekoah,et al. Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience. , 2015, Plant biotechnology journal.
[10] Sylvain Marcel,et al. Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals. , 2015, Plant biotechnology journal.
[11] Friedrich Altmann,et al. Controlled glycosylation of plant-produced recombinant proteins. , 2014, Current opinion in biotechnology.
[12] J. Strong,et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.
[13] D. Bosch,et al. N-glycosylation of plant-produced recombinant proteins. , 2013, Current pharmaceutical design.
[14] Jonathan Hurtado,et al. Agroinfiltration as an Effective and Scalable Strategy of Gene Delivery for Production of Pharmaceutical Proteins , 2013, Advanced techniques in biology & medicine.
[15] 토마스 라데마허. Method for the generation and cultivation of a plant cell pack , 2013 .
[16] W. Curtis,et al. RNA viral vectors for improved Agrobacterium-mediated transient expression of heterologous proteins in Nicotiana benthamiana cell suspensions and hairy roots , 2012, BMC Biotechnology.
[17] K. McDonald,et al. Bioreactor systems for in vitro production of foreign proteins using plant cell cultures. , 2012, Biotechnology advances.
[18] N. Bohorova,et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant , 2011, Proceedings of the National Academy of Sciences.
[19] K. McDonald,et al. Transient Co-Expression of Post-Transcriptional Gene Silencing Suppressors for Increased in Planta Expression of a Recombinant Anthrax Receptor Fusion Protein , 2011, International journal of molecular sciences.
[20] M. Jolicoeur,et al. Transient expression of antibodies in suspension plant cell suspension cultures is enhanced when co‐transformed with the tomato bushy stunt virus p19 viral suppressor of gene silencing , 2010, Biotechnology progress.
[21] Archana Belle,et al. Recombinant Anthrax Toxin Receptor-Fc Fusion Proteins Produced in Plants Protect Rabbits against Inhalational Anthrax , 2010, Antimicrobial Agents and Chemotherapy.
[22] L. Vézina,et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. , 2010, Plant biotechnology journal.
[23] S. Leppla,et al. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo , 2009, Proceedings of the National Academy of Sciences.
[24] A. Dandekar,et al. Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures , 2009, Biotechnology and bioengineering.
[25] J. Collens,et al. Agrobacterium‐Mediated Viral Vector‐Amplified Transient Gene Expression in Nicotiana glutinosa Plant Tissue Culture , 2008, Biotechnology progress.
[26] W. Curtis,et al. Comparison of Transient Protein Expression in Tobacco Leaves and Plant Suspension Culture , 2008, Biotechnology progress.
[27] G. Stiegler,et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.
[28] W. Curtis,et al. Scale‐Up of Agrobacterium‐Mediated Transient Protein Expression in Bioreactor‐Grown Nicotiana glutinosa Plant Cell Suspension Culture , 2008, Biotechnology progress.
[29] Florian M. Wurm,et al. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives , 2007, Biotechnology Letters.
[30] John A. Young,et al. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] F. Skoog,et al. A revised medium for rapid growth and bio assays with tobacco tissue cultures , 1962 .
[32] Ting-Kuo Huang,et al. Development of plant cell suspension cultures as a bioproduction platform for recombinant human therapeutic proteins , 2009 .
[33] J. Collens,et al. Development of Auxotrophic Agrobacterium tumefaciens for Gene Transfer in Plant Tissue Culture , 2004, Biotechnology progress.